Modulation of metabolic syndrome by Fibroblast Growth Factor 19 (FGF19)?

Endocrinology

Volumn 145, Issue 6, 2004, Pages 2591-2593

  Strack, Alison M ^a   Myers, Robert W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; CARNITINE PALMITOYLTRANSFERASE INHIBITOR; FIBROBLAST GROWTH FACTOR 19; METFORMIN; RECOMBINANT FIBROBLAST GROWTH FACTOR; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; BODY WEIGHT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; FATTY ACID OXIDATION; HUMAN; METABOLIC RATE; METABOLIC SYNDROME X; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY;

ANIMALS; FIBROBLAST GROWTH FACTORS; HUMANS; METABOLIC SYNDROME X; RECOMBINANT PROTEINS;

EID: 2542470676     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0367     Document Type: Short Survey

References (27)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL 2004 Actual causes of death in the United States, 2000. JAMA 291:1238-1245
2. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C; American Heart Association and National Heart, Lung, and Blood Institute 2004 Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438
3. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM, Soriano R, Corpuz R, Moffat B, Vandlen R, Simmons L, Foster J, Stephan J-P, Tsai SP, Stewart TA 2004 Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145:2594-2603
4. Tomlinson E, Fu L, John L, Hultgren B, Huang X, Renz M, Stephan JP, Tsai SP, Powell-Braxton L, French D, Stewart TA 2002 Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143:1741-1747
5. Kozak LP, Harper M-E 2000 Mitochondrial uncoupling proteins in energy expenditure. Annu Rev Nutr 20:339-363
6. Fogteloo A, Pijl H, Frolich M, McCamish M, Meinders A 2003 Effect of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. Diabetes Nutr Metab 16:109-114
7. Mayer J, Purnima R, Kamakhya-Prasad M 1956 Relation between caloric intake, body weight, and physical work: studies in an industrial male population in west Bengal. Am J Clin Nutr 4:169-175
8. Hauner H 1999 The impact of pharmacotherapy on weight management in type 2 diabetes. Int J Obes 23:S12-S17
9. Abu-Elheiga L, Matzuk MM, Abo-Hashema KAH, Wakil SJ 2001 Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613-2616
10. Abu-Elheiga L, Oh W, Kordari P, Wakil SJ 2003 Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA 100:10207-10212
11. Harwood Jr HJ, Petras SF, Shelly LD, Zaccaro LM, Perry DA, Makowski MR, Hargrove DM, Martin KA, Tracey WR, Chapman JG, Magee WP, Dalvie DK, Soliman VF, Martin WH, Mularski CJ, Eisenbeis SA 2003 Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J Biol Chem 278:37099-37111
12. Kurukulasuriya R, Link JT, Madar DJ, Pei Z, Richards SJ, Rohde JJ, Souers AJ, Szczepankiewicz BG 2003 Potential drug targets and progress towards pharmacologic inhibition of hepatic glucose production. Curr Med Chem 10:123-153
13. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD 2002 Loss of stearoyl-CoA desarurase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99:11482-11486
14. Ozawa K, Uruno T, Miyakawa K, Seo M, Imamura T 1996 Expression of the fibroblast growth factor family and their receptor family genes during mouse brain development. Mol Brain Res 41:279-288
15. Carl M, Wittbrodt J 1999 Graded interference with FGF signalling reveals its dorsoventral asymmetry at the mid-hindbrain boundary. Development 126:5659-5667
16. Cool SM, Sayer RE, van Heumen WR, Pickles JO, Nurcombe V 2002 Temporal and spatial expression of fibroblast growth factor receptor 4 isoforms in murine tissues. Histochem J 34:291-297
17. Fuhrmann V, Kinkl N, Leveillard T, Sahel J, Hicks D 1999 Fibroblast growth factor receptor 4 (FGFR4) is expressed in adult rat and human retinal photoreceptors and neurons. J Mol Neurosci 13:187-197
18. Xie MH, Holcomb I, Deuel B, Dowd P, Huang A, Vagts A, Foster J, Liang J, Brush J, Gu Q, Hillan K, Goddard A, Gurney AL 1999 FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 11:729-735
19. Matsumoto I, Niijima A, Oomura Y, Sasaki K, Tsuchiya K, Aikawa T 1998 Acidic fibroblast growth factor activates adrenomedullary secretion and sympathetic outflow in rats. Am J Physiol 275(4 Pt 2):R1003-R1012
20. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M 1996 Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297
21. Kim EK, Miller I, Landree LE, Borisy-Rudin FF, Brown P, Tihan T, Townsend CA, Witters LA, Moran TH, Kuhajda FP, Ronnett GV 2002 Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. Am J Physiol Endocrinol Metab 283:E867-E879
22. Gao S, Lane MD 2003 Effect of the anorectic fatty acid synthase inhibitor C75 on neuronal activity in the hypothalamus and brainstem. Proc Natl Acad Sci USA 100:5628-5633
23. Powers CJ, McLeskey SW, Wellstein A 2000 Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7:165-197
24. Wang J-K, Goldfarb M 1997 Amino acid residues which distinguish the mitogenic potentials of two FGF receptors. Oncogene 14:1767-1778
25. Nicholes K, Guillet S, Tomlinson E, Hillan K, Wright B, Frantz GD, Pham TA, Dillard-Telm L, Tsai SP, Stephan JP, Stinson J, Stewart T, French DM 2002 A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol 160:2295-2307
26. Yu C, Wang F, Kan M, Jin C, Jones RB, Weinstein M, Deng CX, McKeehan WL 2000 Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem 275:15482-15489
27. Katoh M, Katoh M 2003 Evolutionary conservation of CCND1-ORAOV1-FGF19- FGF4 locus from zebrafish to human. Int J Mol Med 12:45-50